Transcriptomics

Dataset Information

0

Gene Expression Analysis of Papillary Thyroid Carcinoma with Lymph Node Metastasis and Radioactive Iodine Refractive


ABSTRACT: Radioiodine therapy (RAI) is a safe and effective treatment for DTC. It significantly increases the life expectancy of DTC patients. However, 60% of patients with recurrent or distant metastatic PTC will be radioiodine refractory (RAI-R), where 131I uptake does not occur. Patients with RAI-R thyroid cancer have a poor outcome, with a 5-year disease-specific survival rate of 60% to 70%. Therefore, resensitization of RAI-R tumours to RAI has the potential to improve survival for DTC patients. Therefore, we used the Agilent One-Colour SurePrint G3 Human Gene Expression V3 Microarray on primary thyroid tumours of 5 PTC patients with negative LN and RAI-avid, 5 PTC patients with positive LN and non-RAI-avid and 4 adjacent normal thyroid tissues to identify potential genes involved in iodine uptake. The extracted microarray data was analysed using AltAnalyze and NetworkAnalyst software to determine differentially expressed probesets. We used p-value < 0.05 and log2 fold change ≥1 or ≤-1 as the criteria for chosen significantly differentially probesets. Then, we used ShinyGo to annotate the probesets, determine gene type, and distribution analysis. We also used FunRich to make VennDiagram.

ORGANISM(S): Homo sapiens

PROVIDER: GSE299988 | GEO | 2025/08/06

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2020-11-24 | GSE151179 | GEO
2021-05-17 | GSE151180 | GEO
2022-06-09 | PXD007971 | Pride
2011-08-21 | E-GEOD-15740 | biostudies-arrayexpress
2011-08-22 | GSE15740 | GEO
2022-11-05 | PXD037968 |
2021-09-19 | GSE184362 | GEO
2017-05-03 | PXD002732 | Pride
2020-12-02 | GSE162525 | GEO
2020-12-02 | GSE162523 | GEO